首页|连续性血液净化治疗重症心衰合并肾衰竭的应用分析

连续性血液净化治疗重症心衰合并肾衰竭的应用分析

扫码查看
目的 探讨对重症心力衰竭(以下简称"心衰")合并肾衰竭患者给予连续性血液净化治疗后获得的临床效果.方法 回顾性选取2022年7月—2023年7月淄川区医院72例重症心衰合并肾衰竭患者的临床资料,依据不同的治疗方法分为两组;参照组(n=36)采用常规血液透析,研究组(n=36)采用连续性血液净化,比较两组治疗结果.结果 研究组治疗总有效率(97.22%)显著高于参照组(77.78%),差异有统计学意义(χ2=4.571,P<0.05);治疗后研究组心功能、生命体征、肾功能改善均优于参照组,差异有统计学意义(P均<0.05).结论 临床重症心衰合并肾衰竭患者在治疗期间,连续性血液净化疗法的有效实施,可将患者的疗效提升,改善心、肾功能及生命体征.
Application Analysis of Continuous Blood Purification in the Treatment of Severe Heart Failure Combined with Renal Failure
Objective To explore the clinical effects obtained after continuous blood purification therapy on patients with severe heart failure combined with renal failure.Methods The clinical data of 72 patients with severe heart fail-ure combined with renal failure were retrospectively selected from Zichuan District Hospital from July 2022 to July 2023,and were divided into two groups based on different treatment methods.Reference group(36 cases)was treated with conventional hemodialysis method.Study group(36 cases)was treated with continuous blood purification method.The treatment outcomes of the two groups were compared.Results The total treatment effective rate of the study group(97.22%)was significantly higher than that of the reference group(77.78%),and the difference was statistically signifi-cant(χ2=4.571,P<0.05).After treatment,the improvement in cardiac function,vital signs,and renal function in the study group were better than those in the reference group,respectively,and the difference were statistically significant(all P<0.05).Conclusion Clinical patients with severe heart failure combined with renal failure during the treatment,the effective implementation of continuous blood purification therapy can enhance the efficacy of patients and improve the series of indicators.

Severe heart failureRenal failureContinuous blood purificationTherapeutic efficacyCardiac functionVital signs

王菲菲、王玉环、张克钰

展开 >

淄川区医院肾病科,山东淄博 255100

淄博市精神卫生中心MECT室,山东淄博 255100

重症心衰 肾衰竭 连续性血液净化 疗效 心功能 生命体征

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(11)